newsfilter
← Latest News
GlobeNewswire·

BridgeBio Reports First Quarter 2026 Financial Results and Corporate Updates

$194.5 million in total first quarter revenues, comprised of $180.6 million of U.S. Attruby® net product revenue, with strong prescribing growth and patient persistence driving continued commercial momentumContinued